Myasthenia Gravis Treatment Options: What to Know and What to Ask Your Doctor

TL;DR

• Myasthenia gravis treatment often changes over time.
• Treatment may include symptom-relieving medicine, immune-suppressing medicine, hospital-based therapies, surgery or targeted options.
• People living with MG often raise questions about timing, side effects and access to specialist care.
• Preparing two or three focused questions can support a clearer appointment.
• Treatment decisions should always be made with your healthcare team.

Myasthenia gravis, or MG, is an autoimmune condition that affects communication between nerves and muscles. It can cause weakness that changes throughout the day and becomes more noticeable after activity.

You can read more about common myasthenia gravis symptoms, including muscle weakness, drooping eyelids, double vision and changes in swallowing or speech.

At mama health, we hear from people living with MG about what treatment feels like in everyday life. Their experiences show that treatment is rarely a straight line. A medicine may help but create side effects. A dose may work in the morning but wear off later. A treatment may exist but require specialist review before it can be considered.

This article reflects themes shared with mama health by UK adults living with confirmed MG. It provides educational information and questions that could help you prepare for a conversation with your doctor.

What does myasthenia gravis treatment usually look like?

MG treatment usually develops in stages.

Some people begin with medicine that temporarily improves muscle strength. Others later add treatment that reduces immune-system activity. Hospital-based therapies, surgery or targeted medicines may be considered in certain situations.

The main treatment groups include:

• Pyridostigmine for symptom relief.
• Corticosteroids such as prednisolone.
• Immunosuppressants such as azathioprine or mycophenolate.
• IVIG or plasma exchange during severe worsening.
• Thymectomy for selected people.
• Rituximab or newer targeted medicines for some forms of difficult-to-control MG.

Not everyone follows the same path. Symptoms, antibody results, treatment response, side effects and other health needs can all influence the discussion.

Learning more about living with fluctuating muscle weakness may also help you identify which parts of daily life you want to discuss with your healthcare team.

A question you could ask:

“Where am I in the treatment pathway now, and what might lead us to review the next step?”

What should you know about pyridostigmine?

Pyridostigmine is commonly used to provide temporary relief from muscle weakness.

People who shared their experiences with mama health often described a clear pattern: the medicine helped for a period, then weakness returned before the next dose.

This could affect work, meals, washing, walking or caring responsibilities. Some people planned important activities around the times when the medicine worked best.

Digestive side effects were another recurring concern. These included cramps, nausea and loose stools. Some people felt the medicine was essential but difficult to fit comfortably into daily life.

What could you ask about pyridostigmine?

• “Does my dose timing match the parts of the day when I need strength most?”
• “What could I do if the effect wears off before the next dose?”
• “Could my stomach symptoms be related to the medicine?”
• “Would another formulation be relevant to discuss?”
• “Who should I contact if my usual schedule no longer feels manageable?”

Do not change your dose or timing without speaking to the healthcare professional responsible for your prescription.

Some medicines can affect MG symptoms or interact with treatment. Our guide to medicines that may affect MG can help you prepare questions for your doctor or pharmacist.

What should you know about steroids and immunosuppressants?

Steroids and immunosuppressants are used to reduce the immune activity involved in MG.

Prednisolone can help bring symptoms under better control. Azathioprine and mycophenolate may be used as longer-term options or to reduce reliance on steroids.

The experiences shared with mama health show a common trade-off. A treatment may help with MG while also affecting sleep, mood, weight, energy or general wellbeing.

People also described concerns about:

• Long-term steroid use.
• Blood tests and other monitoring.
• Infection risk.
• Symptoms returning during a steroid taper.
• Not knowing how long a medicine might take to help.
• Feeling that side effects were not discussed enough.

These experiences highlight why treatment conversations should include quality of life, not only symptom control.

What could you ask about steroids?

• “What is the goal of my current dose?”
• “Could I have a written taper plan?”
• “What should I do if symptoms return during the taper?”
• “What monitoring might I need?”
• “Who can I contact if side effects become difficult?”

Steroids should not be reduced or stopped suddenly without guidance.

What could you ask about an immunosuppressant?

• “What are we hoping this medicine will change?”
• “When will we review whether it is helping?”
• “Which blood tests will I need?”
• “What should I do if I develop an infection?”
• “What alternatives could we discuss if I cannot tolerate it?”

When might IVIG or plasma exchange be discussed?

IVIG and plasma exchange are hospital-based treatments used when a faster response is needed.

They may be considered during severe worsening, around surgery or during a myasthenic crisis. Their effect is usually temporary.

Some people who spoke with mama health described these therapies as very helpful. Others found them disruptive because of hospital visits, travel, side effects or uncertainty about access.

A recurring concern was not knowing when a flare was serious enough to contact the neurology team or attend hospital. Some people also wanted clearer information about where they would receive urgent treatment.

What could you ask about severe worsening?

• “What changes should I report urgently?”
• “Who should I contact during a flare?”
• “Where would I receive IVIG or plasma exchange?”
• “Is there an escalation plan in my medical record?”
• “What information could I take with me if I need emergency care?”

Sudden severe breathing or swallowing difficulty requires urgent medical assessment. The overview of myasthenia gravis symptoms explains common changes people may notice, but it does not replace emergency advice.

When might thymectomy be considered?

Thymectomy is surgery to remove the thymus gland.

It may be discussed when a thymoma is present or for selected people with generalised MG. Suitability can depend on age, antibody status, MG type, symptoms and surgical risk.

People who had undergone thymectomy described recovery as a gradual process. Any benefit may take time to become clear, and MG treatment may continue after surgery.

What could you ask about thymectomy?

• “Have I been assessed for a thymoma?”
• “Is thymectomy relevant to my type of MG?”
• “What benefits might be realistic for me?”
• “What would recovery involve?”
• “Would my current medicines continue after surgery?”

When might targeted medicines be discussed?

Targeted medicines may be considered when established treatments have not provided enough control or have caused difficult side effects.

The mama health report describes rituximab as an option that may be considered through specialist NHS pathways for certain forms of difficult-to-control MG. It also highlights growing interest in newer targeted medicines.

People living with MG often described access as confusing. Common questions included whether they met specialist criteria, whether they needed a referral and who was responsible for reviewing advanced treatment options.

Access rules can change. Your neurology team can explain the latest NHS and NICE position and how it may relate to your circumstances.

What could you ask about targeted options?

• “Would my antibody status affect which options could be considered?”
• “Is my MG considered difficult to control?”
• “Would specialist-centre review be relevant?”
• “Could rituximab be appropriate to discuss?”
• “Are there other targeted treatments or research studies that may be relevant?”
• “Who is responsible for reviewing these options?”

Why does specialist coordination matter?

Specialist coordination matters because MG care may involve several services.

Neurology, neuromuscular teams, pharmacy, respiratory care, infusion services and surgery may all be involved. People who shared their experiences with mama health often wanted clearer answers about who was coordinating their care.

This was especially important when symptoms changed, side effects became difficult or hospital-based treatment was being considered.

What could you ask about your care team?

• “Am I under the care of a neuromuscular specialist?”
• “Who is coordinating my MG care?”
• “Who reviews my medicines and test results?”
• “Who should I contact between appointments?”
• “Which service should another doctor contact before prescribing a new medicine?”

What should you take to your next appointment?

A short summary can help you explain how treatment affects your daily life.

You could note:

• Which medicines you take.
• When you take them.
• When their effects seem to wear off.
• Side effects that affect your day.
• Activities that have become harder.
• Recent changes in swallowing, speaking or breathing.
• The two or three questions that matter most to you.

At mama health, we believe lived experience belongs in the treatment conversation. Reflecting on what happens between appointments can help you describe your concerns more clearly.

The goal is not to arrive with every answer. It is to arrive with questions that reflect your life.

For more educational guidance, shared experiences and tips on living with myasthenia gravis, explore the mama health app.

From mama health

mama health brings together lived experiences from people living with chronic conditions. These insights can help you feel more prepared, informed and understood when speaking with your healthcare team.

‍
This content is informational and not a medical device.

mama health offers information and support and does not replace a doctor.

1. NHS. Myasthenia gravis treatment information.
2. National Institute for Health and Care Excellence. Myasthenia gravis technology appraisal guidance.

‍